Polycyclic thyroid hormone beta receptor agonist and use thereof
AssigneeCascade Pharmaceuticals, Inc.
InventorsJingjing Shi, Shengsheng Yang, Linpei Gong, Peng Wang, Xin Zhu
Life of this patent
Estimating the term…
Abstract
The present invention relates to a polycyclic thyroid hormone β receptor agonist and use thereof, in particular, to a compound represented by formula (1) or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising same, a preparation method therefor, and use thereof. The compound or the pharmaceutical composition of the present invention can be used for preparing a drug for preventing, treating, or relieving diseases regulated by the thyroid hormone β receptor.
Claims19
A compound having a structure of formula (1) or a pharmaceutically acceptable salt thereof:
- wherein
- G1 is
- —O—(C1-6 alkylene)-G2, —NH—(C1-6 alkylene)-G2, —NHCO—(C1-6 alkylene)-G2 or —NHCO-G2;
- G2 is —COOH, —P(═O)(OH)2, —P(═O)(OC1-6 alkyl)2,
- R4 and R5 are independently H, halogen, —CN, —NH2, —NO2, —OH, C1-6 alkyl, —O(C1-6 alkyl), —COO(C1-6 alkyl), C2-6 alkenyl, C2-6 alkynyl or C3-8 cycloalkyl;
- said C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl or C3-8 cycloalkyl is optionally substituted with one or more substituents that are independently deuterium, halogen, —CN, —NH2, —NO2 or —OH;
- R2 and R3 are independently H, halogen, —CN, —NH2, —NO2, —OH or C1-6 alkyl;
- said C1-6 alkyl is optionally substituted with one or more substituents that are independently halogen, —CN, —NH2, —NO2 or —OH;
- R6 is H, —COOH, —COO(C1-6 alkyl), —CONH(C1-6 alkyl) or —CONH(C3-8 cycloalkyl);
- said C1-6 alkyl or C3-8 cycloalkyl is optionally substituted with one or more substituents that are independently halogen, —CN, —NH2, —NO2 or —OH;
- R7 and R3 are independently H or deuterium;
- each R1 is independently H, halogen, —CN, —NH2, —NO2, —OH, C1-6 alkyl, —O(C1-6 alkyl) or —COO(C1-6 alkyl);
- said C1-6 alkyl is optionally substituted with one or more substituents that are independently halogen, —CN, —NH2, —NO2 or —OH;
- and
- m is 0, 1, 2, 3 or 4.
A compound or a pharmaceutically acceptable salt thereof, wherein the compound is selected from the group consisting of:
Dependencies are inferred from the claim text.